Application of Dual Spectrum SRS Imaging in Rapid Detection of Renal Tumor

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037536

Enrollment

Unknown

Registered

2020-08-28

Start date

2022-09-30

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Tumor

Interventions

renal tumor:Dual Spectrum SRS Imaging irradiation

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Histopathologic sections of tumor after renal tumor operation

Exclusion criteria

Exclusion criteria: Pathological sections of postoperative tissues of patients with other renal diseases

Design outcomes

Primary

Measure	Time frame
Lipid/protein ratio in dual Spectrum SRS Image;	—

Countries

China

Contacts

Public ContactZhuang Likai

Children's Hospital of Fudan University

lszx04336@163.com+86 13636412046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026